作者
Chilukuri N Rao, Sajani S Lakka, Yoshiaki Kin, Santhi D Konduri, Gregory N Fuller, Sanjeeva Mohanam, Jasti S Rao
发表日期
2001/3/1
期刊
Clinical cancer research
卷号
7
期号
3
页码范围
570-576
出版商
American Association for Cancer Research
简介
Protease inhibitors regulate a variety of physiological and pathological processes including angiogenesis, embryo implantation, intravascular fibrinolysis, wound healing, and tumor invasion. Tissue factor pathway inhibitor (TFPI) 2 is a Mr 32,000 Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not urokinase-type plasminogen activator, tissue plasminogen activator, or thrombin. In this study, we determined the relative amounts of TFPI-2 in low-, intermediate-, and high-grade human glioma cell lines and tumor tissue samples. TFPI-2 protein and mRNA levels (measured by Western and Northern blotting) were highest in low-grade glioma cells (Hs683), lower in anaplastic astrocytoma cells (SW1088 and SW1783), and undetectable in high-grade glioma cells (SNB19). Analysis of TFPI-2 protein in human normal brain and in glioma tumor …
引用总数
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202424134124934555553232114243
学术搜索中的文章